Anna Kathy Aman

Array ( [id] => 7499183 [patent_doc_number] => 20110262364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Fluorescent Particles Comprising Nanoscale ZnO Layer and Exhibiting Cell-Specific Toxicity' [patent_app_type] => utility [patent_app_number] => 13/079469 [patent_app_country] => US [patent_app_date] => 2011-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13796 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262364.pdf [firstpage_image] =>[orig_patent_app_number] => 13079469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355436 [patent_doc_number] => 08673969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Substituted 4-β-acrylamidopodophyllotoxin congeners as antitumour antibiotics and the process for preparation thereof' [patent_app_type] => utility [patent_app_number] => 13/883938 [patent_app_country] => US [patent_app_date] => 2011-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7747 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099660 [patent_doc_number] => 08563538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Preventing and/or treating cardiovascular disease and/or associated heart failure' [patent_app_type] => utility [patent_app_number] => 13/037223 [patent_app_country] => US [patent_app_date] => 2011-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 32771 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13037223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8708625 [patent_doc_number] => 20130065914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'HALOGEN OR CYANO SUBSTITUTED THIENO [2,3-D]PYRIMIDINES HAVING MNK1/MNK2 INHIBITING ACTIVITY FOR PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/580184 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17379 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13580184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720090 [patent_doc_number] => 20120009425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'PROCESS FOR SYNTHESIZING SILVER-SILICA PARTICLES AND APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 13/031588 [patent_app_country] => US [patent_app_date] => 2011-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14782 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009425.pdf [firstpage_image] =>[orig_patent_app_number] => 13031588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371247 [patent_doc_number] => 20120220641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'LASER ENHANCED AMINO ACID BLEND AND USE OF SAME TO REGENERATE ACTIVE MYOCARDIAL TISSUE' [patent_app_type] => utility [patent_app_number] => 13/026454 [patent_app_country] => US [patent_app_date] => 2011-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6579 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13026454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10121378 [patent_doc_number] => 09155724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Combination methods for treatment of disease' [patent_app_type] => utility [patent_app_number] => 13/577098 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 57 [patent_no_of_words] => 47535 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664511 [patent_doc_number] => 08377972 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Use of quaternary pyridinium compounds for vasoprotection and/or hepatoprotection' [patent_app_type] => utility [patent_app_number] => 13/011364 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 5584 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13011364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055734 [patent_doc_number] => 20110112094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Methods of Treating Pulmonary Hypertension' [patent_app_type] => utility [patent_app_number] => 13/006592 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 32714 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112094.pdf [firstpage_image] =>[orig_patent_app_number] => 13006592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555270 [patent_doc_number] => 08329743 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Compositions and its use in treating obesity or inducing weight loss' [patent_app_type] => utility [patent_app_number] => 12/987326 [patent_app_country] => US [patent_app_date] => 2011-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2614 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12987326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846340 [patent_doc_number] => 08455523 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Compositions and methods for treating hyperlipidemias' [patent_app_type] => utility [patent_app_number] => 12/930532 [patent_app_country] => US [patent_app_date] => 2011-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 13070 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12930532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7509810 [patent_doc_number] => 20110256073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Formulations for treating and/or preventing Black-Line Stains' [patent_app_type] => utility [patent_app_number] => 12/985112 [patent_app_country] => US [patent_app_date] => 2011-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2739 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256073.pdf [firstpage_image] =>[orig_patent_app_number] => 12985112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675563 [patent_doc_number] => 08383678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Type a gelatin capsule containing PUFA in free acid form' [patent_app_type] => utility [patent_app_number] => 12/984994 [patent_app_country] => US [patent_app_date] => 2011-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3919 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12984994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571810 [patent_doc_number] => 08338456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Cut-point in PTEN protein expression that accurately identifies tumors and is predictive of drug response to a pan-ErbB inhibitor' [patent_app_type] => utility [patent_app_number] => 12/984043 [patent_app_country] => US [patent_app_date] => 2011-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4783 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12984043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6215449 [patent_doc_number] => 20110137285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'KIT OF TAMPONING LIQUIDS AND A METHOD FOR THE TREATMENT OF TEARS AND/OR DETACHMENTS OF THE RETINA USING SUCH LIQUIDS' [patent_app_type] => utility [patent_app_number] => 12/960186 [patent_app_country] => US [patent_app_date] => 2010-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3377 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20110137285.pdf [firstpage_image] =>[orig_patent_app_number] => 12960186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8394315 [patent_doc_number] => 20120232152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'TOPICAL IBUPROFEN FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 13/511287 [patent_app_country] => US [patent_app_date] => 2010-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16599 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626660 [patent_doc_number] => 08796340 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Pharmaceutical composition comprising propofol' [patent_app_type] => utility [patent_app_number] => 13/511184 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5703 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10031449 [patent_doc_number] => 09072750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Use of prostaglandins F2Alpha and analogues for the healing of corneal and conjunctival lesions' [patent_app_type] => utility [patent_app_number] => 13/510884 [patent_app_country] => US [patent_app_date] => 2010-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5193 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8394278 [patent_doc_number] => 20120232123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'LIQUID PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/510650 [patent_app_country] => US [patent_app_date] => 2010-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4105 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10018560 [patent_doc_number] => 09061029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Method of treating proliferative disorders and other pathological conditions mediated by Bcr-Abl, c-Kit, DDR1, DDR2 or PDGF-R kinase activity' [patent_app_type] => utility [patent_app_number] => 13/509626 [patent_app_country] => US [patent_app_date] => 2010-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5290 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509626 [rel_patent_id] =>[rel_patent_doc_number] =>)